IPC Signs MoUs with PMBI and NIPER for Drug Quality

IPC and PMBI MoU enhances quality testing for Jan Aushadhi medicines, promotes rational drug use, and strengthens pharmacovigilance with helpline display.
IPC and NIPER Hajipur MoU focuses on collaborative research for impurity profiling, biologics standards, and analytical method development.
Both partnerships include joint training programs, workshops, and capacity building initiatives to improve pharmaceutical standards and patient safety.